Office: South San Francisco, CA

Ian Clark
Operating Partner

Ian Clark serves as an Operating Partner for the firm.

Prior to joining Clarus Mr. Clark served as Chief Executive Officer of Genentech and as Head of Roche’s North American Commercial Operations for over 7 years. Mr. Clark began his career at Genentech in 2003, serving 12 of his 14 years on the Executive Committee, holding positions such as, Senior Vice President Bio-oncology, Executive Vice President Commercial Operations, and Head of Global Product Strategy and Chief Marketing Officer. During his tenure at Genentech Mr. Clark led and executed the launch of over 14 novel FDA approved new molecular entities, including Avastin® and Tecentriq®.

Prior to Genentech Mr. Clark worked for 20 years in the Bio-Pharma industry in positions on increasing seniority in Canada, UK, France, and Eastern Europe.

Currently, Mr.Clark serves on the boards of Agios Pharmaceuticals, Inc. (NASDAQ: AGIO),Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), Kite Pharmaceuticals (NASDAQ:KITE), and Shire PLC (NASDAQ: SHPG). He also serves on the boards of directors of the Biotechnology Industry Organization (BIO) and the Gladstone Foundation, and is a member of the Federal Reserve Bank of San Francisco’s Economic Advisory Council. Mr. Clark received a bachelor of science degree and an honorary doctorate in Biological Sciences from Southampton University in the United Kingdom.

Clarus Board Seats